
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $9.5B | -- | -- | -- | -- |
07/29/2025 | Q2 | $9.5B | -- | -- | -- | -- |
04/30/2025 | Q1 | $9.7B | $9.7B | $0.16 | -- | -- |
02/13/2025 | Q4 | $8.2B | $8.2B | $0.09 | -- | -- |
10/24/2024 | Q3 | $8.3B | $8.5B | $0.14 | -- | -- |
08/01/2024 | Q2 | $8.1B | $8B | $0.10 | -- | -- |
04/25/2024 | Q1 | $8.4B | $8.8B | $0.13 | -- | -- |
02/20/2024 | Q4 | $7.3B | $7B | -$0.01 | -- | -- |
10/24/2023 | Q3 | -- | -- | $0.11 | -- | -- |
07/27/2023 | Q2 | -- | -- | $0.11 | -- | -- |
04/27/2023 | Q1 | -- | -- | $0.14 | -- | -- |
02/15/2023 | Q4 | -- | -- | $0.08 | -- | -- |
10/26/2022 | Q3 | -- | -- | $0.11 | -- | -- |
07/28/2022 | Q2 | -- | -- | $0.08 | -- | -- |
04/28/2022 | Q1 | -- | -- | $0.11 | -- | -- |
02/23/2022 | Q4 | -- | -- | $0.10 | -- | -- |
10/21/2021 | Q3 | -- | -- | $0.12 | -- | -- |
07/28/2021 | Q2 | -- | -- | $0.17 | -- | -- |
04/30/2021 | Q1 | -- | -- | $0.14 | -- | -- |
02/18/2021 | Q4 | -- | -- | $0.02 | -- | -- |
10/23/2020 | Q3 | -- | -- | $0.05 | -- | -- |
07/29/2020 | Q2 | -- | -- | $0.01 | -- | -- |
04/29/2020 | Q1 | -- | -- | $0.04 | -- | -- |
02/13/2020 | Q4 | -- | -- | $0.05 | -- | -- |
10/25/2019 | Q3 | -- | -- | -$0.02 | -- | -- |
08/01/2019 | Q2 | -- | -- | $0.08 | -- | -- |
04/25/2019 | Q1 | -- | -- | $0.08 | -- | -- |
02/21/2019 | Q4 | -- | -- | -$0.00 | -- | -- |
10/24/2018 | Q3 | -- | -- | $0.08 | -- | -- |
08/02/2018 | Q2 | -- | -- | $0.10 | -- | -- |
04/26/2018 | Q1 | -- | -- | -$0.06 | -- | -- |
02/22/2018 | Q4 | -- | -- | -$0.10 | -- | -- |
10/26/2017 | Q3 | -- | -- | $0.04 | -- | -- |
07/28/2017 | Q2 | -- | -- | -$0.11 | -- | -- |
04/28/2017 | Q1 | -- | -- | $0.02 | -- | -- |
02/23/2017 | Q4 | -- | -- | $0.01 | -- | -- |
10/27/2016 | Q3 | -- | -- | $0.03 | -- | -- |
07/29/2016 | Q2 | -- | -- | $0.06 | -- | -- |
04/27/2016 | Q1 | -- | -- | $0.04 | -- | -- |
03/01/2016 | Q4 | -- | -- | -$0.22 | -- | -- |
10/29/2015 | Q3 | -- | -- | $0.04 | -- | -- |
Barclays PLC reported $9.7B worth of top line sales in its most recent quarter.
Barclays PLC announced earnings per share of $0.16 which represents a beat of analyst forecast a -- per share.
Barclays PLC reported -- that represents -- per share over the last quarter.
Barclays PLC's earnings are forecast to grow from $0.44 per share to -- per share next year representing an increase of --.
Barclays PLC's next earnings date is July 29, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.